These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 6235071)

  • 1. In vitro and in vivo actions of acetylcholine receptor educated suppressor T cell lines in murine experimental autoimmune myasthenia gravis.
    Pachner AR; Kantor FS
    Clin Exp Immunol; 1984 Jun; 56(3):659-68. PubMed ID: 6235071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular immune response to acetylcholine receptors in murine experimental autoimmune myasthenia gravis: inhibition with monoclonal anti-I-A antibodies.
    Christadoss P; Lindstrom J; Talal N
    Cell Immunol; 1983 Oct; 81(1):1-8. PubMed ID: 6577968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of suppressor cells specific for AChR in experimental autoimmune myasthenia gravis.
    McIntosh KR; Drachman DB
    Science; 1986 Apr; 232(4748):401-3. PubMed ID: 2938256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon gamma (IFN-gamma) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune myasthenia gravis in mice.
    Balasa B; Deng C; Lee J; Bradley LM; Dalton DK; Christadoss P; Sarvetnick N
    J Exp Med; 1997 Aug; 186(3):385-91. PubMed ID: 9236190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How subtle differences in MHC class II affect the severity of experimental myasthenia gravis.
    Yang B; McIntosh KR; Drachman DB
    Clin Immunol Immunopathol; 1998 Jan; 86(1):45-58. PubMed ID: 9434796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of experimental autoimmune myasthenia gravis with acetylcholine receptors using a nonionic block copolymer as adjuvant.
    Shenoy M; Christadoss P
    Immunol Invest; 1993 Jun; 22(4):267-82. PubMed ID: 8359864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Animal models of myasthenia gravis.
    Christadoss P; Poussin M; Deng C
    Clin Immunol; 2000 Feb; 94(2):75-87. PubMed ID: 10637092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell reactivity to acetylcholine receptor in rats orally tolerized against experimental autoimmune myasthenia gravis.
    Wang ZY; Qiao J; Melms A; Link H
    Cell Immunol; 1993 Dec; 152(2):394-404. PubMed ID: 8258147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy for myasthenia gravis: a murine model.
    Christadoss P; Dauphinee MJ
    J Immunol; 1986 Apr; 136(7):2437-40. PubMed ID: 2419435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity of the T cell immune response to acetylcholine receptor in experimental autoimmune myasthenia gravis. Response to subunits and synthetic peptides.
    Fujii Y; Lindstrom J
    J Immunol; 1988 Mar; 140(6):1830-7. PubMed ID: 2450133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B cell responses to acetylcholine receptor in rats orally tolerized against experimental autoimmune myasthenia gravis.
    Wang ZY; Huang J; Olsson T; He B; Link H
    J Neurol Sci; 1995 Feb; 128(2):167-74. PubMed ID: 7537794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B cell autoimmunity to acetylcholine receptor and its subunits in Lewis rats over the course of experimental autoimmune myasthenia gravis.
    Wang ZY; Link H; Qiao J; Olsson T; Huang WX
    J Neuroimmunol; 1993 Jun; 45(1-2):103-12. PubMed ID: 8331155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depletion of CD8+ T cells suppresses the development of experimental autoimmune myasthenia gravis in Lewis rats.
    Zhang GX; Ma CG; Xiao BG; Bakhiet M; Link H; Olsson T
    Eur J Immunol; 1995 May; 25(5):1191-8. PubMed ID: 7774622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectrotypic analysis of antibodies to acetylcholine receptors in experimental autoimmune myasthenia gravis.
    Bionda A; De Baets MH; Tzartos SJ; Lindstrom JM; Weigle WO; Theophilopoulos AN
    Clin Exp Immunol; 1984 Jul; 57(1):41-50. PubMed ID: 6611231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental autoimmune myasthenia gravis in B10.BV8S2 transgenic mice: preferential usage of TCRAV1 gene by lymphocytes responding to acetylcholine receptor.
    Kaul R; Wu B; Goluszko E; Deng C; Dedhia V; Nabozny GH; David CS; Rimm IJ; Shenoy M; Haqqi TM; Christadoss P
    J Immunol; 1997 Jun; 158(12):6006-12. PubMed ID: 9190955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An immunodominant site of acetylcholine receptor in experimental myasthenia mapped with T lymphocyte clones and synthetic peptides.
    Pachner AR; Kantor FS; Mulac-Jericevic B; Atassi MZ
    Immunol Lett; 1989 Feb; 20(3):199-204. PubMed ID: 2469649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of experimental autoimmune myasthenia gravis by oral administration of acetylcholine receptor.
    Wang ZY; Qiao J; Link H
    J Neuroimmunol; 1993 May; 44(2):209-14. PubMed ID: 8505410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TCR gene usage in experimental autoimmune myasthenia gravis pathogenesis. Usage of multiple TCRBV genes in the H-2b strains.
    Wu B; Shenoy M; Goluszko E; Kaul R; Christadoss P
    J Immunol; 1995 Apr; 154(7):3603-10. PubMed ID: 7897239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of experimental autoimmune myasthenia gravis by manipulation of the immune network with a complementary peptide for the acetylcholine receptor.
    Araga S; LeBoeuf RD; Blalock JE
    Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8747-51. PubMed ID: 8378359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profile of the regions of acetylcholine receptor alpha chain recognized by T-lymphocytes and by antibodies in EAMG-susceptible and non-susceptible mouse strains after different periods of immunization with the receptor.
    Oshima M; Pachner AR; Atassi MZ
    Mol Immunol; 1994 Aug; 31(11):833-43. PubMed ID: 7519305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.